Pramipexole Dihydrochloride Patent Expiration

Pramipexole Dihydrochloride is Used for treating moderate to severe primary Restless Legs Syndrome (RLS). It was first introduced by Boehringer Ingelheim in its drug Mirapex on Jul 1, 1997. Another drug containing Pramipexole Dihydrochloride is Mirapex Er. 24 different companies have introduced drugs containing Pramipexole Dihydrochloride.


Pramipexole Dihydrochloride Patents

Given below is the list of patents protecting Pramipexole Dihydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Mirapex US6001861 Use of pramipexole in the treatment of restless legs syndrome Jan 16, 2018

(Expired)

Boehringer Ingelheim
Mirapex US6194445 Use of pramipexole in the treatment of restless legs syndrome Jan 16, 2018

(Expired)

Boehringer Ingelheim
Mirapex Er US7695734 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof Apr 26, 2028 Boehringer Ingelheim
Mirapex Er US8679533 Pramipexole once-daily dosage form Sep 08, 2029 Boehringer Ingelheim


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Pramipexole Dihydrochloride Generics

Several generic applications have been filed for Pramipexole Dihydrochloride. The first generic version for Pramipexole Dihydrochloride was by Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc and was approved on Feb 19, 2008. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Nov 23, 2022.

Given below is the list of companies who have filed for Pramipexole Dihydrochloride generic.


1. NOSTRUM LABS INC

Nostrum Laboratories Inc has filed for 5 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Nostrum Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.125MG tablet Discontinued ORAL N/A Oct 8, 2010
0.25MG tablet Discontinued ORAL N/A Oct 8, 2010
0.5MG tablet Discontinued ORAL N/A Oct 8, 2010
1MG tablet Discontinued ORAL N/A Oct 8, 2010
1.5MG tablet Discontinued ORAL N/A Oct 8, 2010


2. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG tablet Prescription ORAL AB Jun 3, 2014
0.25MG tablet Prescription ORAL AB Jun 3, 2014
0.5MG tablet Prescription ORAL AB Jun 3, 2014
0.75MG tablet Prescription ORAL AB Jun 3, 2014
1MG tablet Prescription ORAL AB Jun 3, 2014
0.125MG tablet Prescription ORAL AB Jun 3, 2014


3. UNICHEM

Unichem Laboratories Ltd has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG tablet Discontinued ORAL N/A Dec 19, 2018
0.125MG tablet Discontinued ORAL N/A Dec 19, 2018
0.25MG tablet Discontinued ORAL N/A Dec 19, 2018
0.75MG tablet Discontinued ORAL N/A Dec 19, 2018
1MG tablet Discontinued ORAL N/A Dec 19, 2018
1.5MG tablet Discontinued ORAL N/A Dec 19, 2018


4. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG tablet Prescription ORAL AB Jul 6, 2010
1MG tablet Prescription ORAL AB Jul 6, 2010
0.5MG tablet Prescription ORAL AB Jul 6, 2010
0.25MG tablet Prescription ORAL AB Jul 6, 2010
0.125MG tablet Prescription ORAL AB Jul 6, 2010
0.75MG tablet Prescription ORAL AB Nov 23, 2022


5. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 11 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.125MG tablet Discontinued ORAL N/A Oct 8, 2010
0.25MG tablet Discontinued ORAL N/A Oct 8, 2010
0.5MG tablet Discontinued ORAL N/A Oct 8, 2010
1MG tablet Discontinued ORAL N/A Oct 8, 2010
1.5MG tablet, extended release Prescription ORAL AB Jan 2, 2019
0.375MG tablet, extended release Prescription ORAL AB Jan 2, 2019
3.75MG tablet, extended release Prescription ORAL AB Jan 2, 2019
4.5MG tablet, extended release Prescription ORAL AB Jan 2, 2019
3MG tablet, extended release Prescription ORAL AB Jan 2, 2019
2.25MG tablet, extended release Prescription ORAL AB Jan 2, 2019
0.75MG tablet, extended release Prescription ORAL AB Jan 2, 2019


6. TORRENT PHARMS

Torrent Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Torrent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.125MG tablet Prescription ORAL AB Oct 8, 2010
0.25MG tablet Prescription ORAL AB Oct 8, 2010
0.5MG tablet Prescription ORAL AB Oct 8, 2010
0.75MG tablet Prescription ORAL AB Oct 8, 2010
1MG tablet Prescription ORAL AB Oct 8, 2010
1.5MG tablet Prescription ORAL AB Oct 8, 2010


7. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG tablet Discontinued ORAL N/A Mar 27, 2013
0.75MG tablet Discontinued ORAL N/A Mar 27, 2013
0.5MG tablet Discontinued ORAL N/A Mar 27, 2013
0.25MG tablet Discontinued ORAL N/A Mar 27, 2013
0.125MG tablet Discontinued ORAL N/A Mar 27, 2013
1MG tablet Discontinued ORAL N/A Mar 27, 2013


8. HERITAGE PHARMA AVET

Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Heritage Pharma Avet.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG tablet Discontinued ORAL N/A Nov 30, 2010
0.125MG tablet Discontinued ORAL N/A Nov 30, 2010
0.25MG tablet Discontinued ORAL N/A Nov 30, 2010
0.5MG tablet Discontinued ORAL N/A Nov 30, 2010
1.5MG tablet Discontinued ORAL N/A Nov 30, 2010
0.75MG tablet Discontinued ORAL N/A Nov 30, 2010


9. ZENNOVA

Zennova Pharmaceuticals Chengdu Co Ltd has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Zennova.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.5MG tablet Prescription ORAL AB Apr 30, 2012
0.25MG tablet Prescription ORAL AB Apr 30, 2012
0.125MG tablet Prescription ORAL AB Apr 30, 2012
1.5MG tablet Prescription ORAL AB Apr 30, 2012
1MG tablet Prescription ORAL AB Apr 30, 2012
0.75MG tablet Prescription ORAL AB Apr 30, 2012


10. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG tablet, extended release Prescription ORAL AB Dec 12, 2017
0.375MG tablet, extended release Prescription ORAL AB Dec 12, 2017
3.75MG tablet, extended release Prescription ORAL AB Dec 12, 2017
3MG tablet, extended release Prescription ORAL AB Dec 12, 2017
2.25MG tablet, extended release Prescription ORAL AB Dec 12, 2017
0.75MG tablet, extended release Prescription ORAL AB Dec 12, 2017
4.5MG tablet, extended release Prescription ORAL AB Dec 12, 2017


11. ACTAVIS ELIZABETH

Actavis Elizabeth Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4.5MG tablet, extended release Prescription ORAL AB Apr 21, 2016
0.375MG tablet, extended release Prescription ORAL AB Apr 21, 2016
0.75MG tablet, extended release Prescription ORAL AB Apr 21, 2016
1.5MG tablet, extended release Prescription ORAL AB Apr 21, 2016
3MG tablet, extended release Prescription ORAL AB Apr 21, 2016
2.25MG tablet, extended release Prescription ORAL AB Oct 14, 2016
3.75MG tablet, extended release Prescription ORAL AB Jan 3, 2017


12. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.75MG tablet Discontinued ORAL N/A Oct 8, 2010
1MG tablet Discontinued ORAL N/A Oct 8, 2010
1.5MG tablet Discontinued ORAL N/A Oct 8, 2010
0.125MG tablet Discontinued ORAL N/A Oct 8, 2010
0.25MG tablet Discontinued ORAL N/A Oct 8, 2010
0.5MG tablet Discontinued ORAL N/A Oct 8, 2010


13. SANDOZ

Sandoz Inc has filed for 9 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG tablet Discontinued ORAL N/A Jul 6, 2010
1.5MG tablet, extended release Prescription ORAL AB Dec 4, 2014
0.125MG tablet Discontinued ORAL N/A Jul 6, 2010
0.5MG tablet Discontinued ORAL N/A Jul 6, 2010
0.25MG tablet Discontinued ORAL N/A Jul 6, 2010
0.75MG tablet, extended release Prescription ORAL AB Dec 4, 2014
4.5MG tablet, extended release Prescription ORAL AB Dec 4, 2014
0.375MG tablet, extended release Prescription ORAL AB Dec 4, 2014
3MG tablet, extended release Prescription ORAL AB Dec 4, 2014


14. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25MG tablet Prescription ORAL AB Oct 28, 2014
0.125MG tablet Prescription ORAL AB Oct 28, 2014
1.5MG tablet Prescription ORAL AB Oct 28, 2014
0.75MG tablet Prescription ORAL AB Oct 28, 2014
0.5MG tablet Prescription ORAL AB Oct 28, 2014
1MG tablet Prescription ORAL AB Oct 28, 2014


15. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 11 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1MG tablet Discontinued ORAL N/A Sep 20, 2012
0.5MG tablet Discontinued ORAL N/A Sep 20, 2012
1.5MG tablet, extended release Prescription ORAL AB Jun 24, 2016
0.25MG tablet Discontinued ORAL N/A Sep 20, 2012
0.125MG tablet Discontinued ORAL N/A Sep 20, 2012
3MG tablet, extended release Prescription ORAL AB Jun 24, 2016
0.75MG tablet, extended release Prescription ORAL AB Jun 24, 2016
2.25MG tablet, extended release Prescription ORAL AB Jun 24, 2016
4.5MG tablet, extended release Prescription ORAL AB Jun 24, 2016
0.375MG tablet, extended release Prescription ORAL AB Jun 24, 2016
3.75MG tablet, extended release Prescription ORAL AB Jan 23, 2017


16. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.125MG tablet Prescription ORAL AB Oct 8, 2010
0.25MG

(reference standard)

tablet Prescription ORAL AB Oct 8, 2010
0.5MG tablet Prescription ORAL AB Oct 8, 2010
1MG tablet Prescription ORAL AB Oct 8, 2010
1.5MG tablet Prescription ORAL AB Oct 8, 2010
0.75MG tablet Prescription ORAL AB Sep 11, 2015


17. MYLAN

Mylan Pharmaceuticals Inc has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.75MG tablet Discontinued ORAL N/A Apr 9, 2010
0.25MG tablet Discontinued ORAL N/A Oct 8, 2010
0.125MG tablet Discontinued ORAL N/A Oct 8, 2010
0.5MG tablet Discontinued ORAL N/A Oct 8, 2010
1MG tablet Discontinued ORAL N/A Oct 8, 2010
1.5MG tablet Discontinued ORAL N/A Oct 8, 2010


18. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 5 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.375MG tablet, extended release Prescription ORAL AB Aug 7, 2015
4.5MG tablet, extended release Prescription ORAL AB Aug 7, 2015
3MG tablet, extended release Prescription ORAL AB Aug 7, 2015
1.5MG tablet, extended release Prescription ORAL AB Aug 7, 2015
0.75MG tablet, extended release Prescription ORAL AB Aug 7, 2015


19. RISING

Rising Pharma Holding Inc has filed for 5 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1.5MG tablet Prescription ORAL AB Oct 3, 2018
1MG tablet Prescription ORAL AB Oct 3, 2018
0.75MG tablet Prescription ORAL AB Oct 3, 2018
0.5MG tablet Prescription ORAL AB Oct 3, 2018
0.25MG tablet Prescription ORAL AB Oct 3, 2018


20. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 6 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.125MG tablet Prescription ORAL AB Oct 26, 2012
0.25MG tablet Prescription ORAL AB Oct 26, 2012
0.5MG tablet Prescription ORAL AB Oct 26, 2012
0.75MG tablet Prescription ORAL AB Oct 26, 2012
1MG tablet Prescription ORAL AB Oct 26, 2012
1.5MG tablet Prescription ORAL AB Oct 26, 2012


21. ENDO OPERATIONS

Endo Operations Ltd has filed for 7 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
4.5MG tablet, extended release Discontinued ORAL N/A Feb 6, 2014
3.75MG tablet, extended release Discontinued ORAL N/A Feb 6, 2014
0.375MG tablet, extended release Discontinued ORAL N/A Feb 6, 2014
0.75MG tablet, extended release Discontinued ORAL N/A Feb 6, 2014
1.5MG tablet, extended release Discontinued ORAL N/A Feb 6, 2014
2.25MG tablet, extended release Discontinued ORAL N/A Feb 6, 2014
3MG tablet, extended release Discontinued ORAL N/A Feb 6, 2014


22. NOVAST LABS

Novast Laboratories Ltd has filed for 7 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Novast Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.25MG tablet, extended release Prescription ORAL AB Feb 3, 2022
0.375MG tablet, extended release Prescription ORAL AB Feb 3, 2022
0.75MG tablet, extended release Prescription ORAL AB Feb 3, 2022
1.5MG tablet, extended release Prescription ORAL AB Feb 3, 2022
4.5MG tablet, extended release Prescription ORAL AB Feb 3, 2022
3.75MG tablet, extended release Prescription ORAL AB Feb 3, 2022
3MG tablet, extended release Prescription ORAL AB Feb 3, 2022


23. XIAMEN LP PHARM CO

Xiamen Lp Pharmacuetical Co Ltd has filed for 2 different strengths of generic version for Pramipexole Dihydrochloride. Given below are the details of the strengths of this generic introduced by Xiamen Lp Pharm Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.375MG tablet, extended release Prescription ORAL AB Jun 11, 2021
0.75MG tablet, extended release Prescription ORAL AB Jun 11, 2021